Compared with peripheral blood and synovial fluid from RA patients, a higher proportion of IL-17-producing ILC3s in the synovial fluid of PsA patients were CCR6+NKp44+, indicating ILC3s might migrate into the inflamed joints through CCR6 in PsA patients [29]. This evidence concerns the gene CCR6 and rheumatoid arthritis.